Dez 6, 2012 | Allgemein, company news @en, DE, general conditions, health policy
Federal Minister of Economics Philipp Rösler and Health Minister Daniel Bahr have emphasized the growing importance of electronic means for the actual medical care situation at the start of 3. Gesundheitswirtschaftskonferenz (conference of the healthcare industry) in...
Dez 6, 2012 | Allgemein, company news @en, DE
In June, AstraZeneca made a start and came to an arrangement with the National Association of Statutory Health Insurance Funds (Spitzenverband der GKV) regarding the reimbursement for blood diluting drug Ticagrelor (Brilique). Since then the pharmaceutical industry...
Dez 6, 2012 | Allgemein, company news @en, DE
Statutory health insurances (GKV) have once again increased their surplus and now have a reserve of EUR 23bn at their command (half year: EUR 21.8bn). A EUR 14bn financial cushion of the insurance companies is complemented by a EUR 9.5bn reserve of the health care...
Dez 6, 2012 | Allgemein, company news @en, DE
Medical technology company Carl Zeiss Meditec increased both business volume and operational result significantly in 2012 (end of of 2012 fiscal year: September 30th). All business divsions and regions contributed to the growth, CEO Ludwin Monz informed the press. All...
Dez 6, 2012 | Allgemein, company news @en, DE
After cutting costs in its Merck Sorono pharma business Darmstadt-based pharmaceutical company Merck has announced that it plans to subject its lab division Millipore to cost cuttings. As of 2017, the company plans net cost savings to the amount of EUR 40m it...
Dez 6, 2012 | Allgemein, company news @en, DE, transactions
Chicago-based private equity company Linden Capital Partners has signed a take-over agreement with Young Innovations in the amount of $39.50 per share. This equates to a price premium 12.5% higher than the prevailing average price for the preceding month. Young...